Necchi A, Raggi D, Gallina A, Ross JS, et al. Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer. Eur Urol 2020 Mar 9. pii: S0302-2838(20)30138.
PMID: 32165065